Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors (Q33151848)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors |
scientific article |
Statements
1 reference
Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors (English)
1 reference
Manisha H Shah
1 reference
Donn Young
1 reference
Hedy L Kindler
1 reference
Iain Webb
1 reference
Barbara Kleiber
1 reference
John Wright
1 reference
Michael Grever
1 reference
1 September 2004
1 reference
1 reference
Identifiers
1 reference